These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34480380)

  • 21. Enzyme replacement therapy in mucopolysaccharidosis type I.
    Miebach E
    Acta Paediatr Suppl; 2005 Mar; 94(447):58-60; discussion 57. PubMed ID: 15895714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I.
    Pjetraj D; Santoro L; Sgattoni C; Padella L; Zampini L; Monachesi C; Gabrielli O; Catassi C
    Am J Med Genet A; 2023 Feb; 191(2):564-569. PubMed ID: 36333985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I.
    Johnson BA; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hurler syndrome: early diagnosis and treatment].
    Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C
    Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life.
    Kingma SD; Langereis EJ; de Klerk CM; Zoetekouw L; Wagemans T; IJlst L; Wanders RJ; Wijburg FA; van Vlies N
    Orphanet J Rare Dis; 2013 Jul; 8():99. PubMed ID: 23837464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan.
    Lin SP; Lin HY; Wang TJ; Chang CY; Lin CH; Huang SF; Tsai CC; Liu HL; Keutzer J; Chuang CK
    Orphanet J Rare Dis; 2013 Sep; 8():147. PubMed ID: 24053568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications.
    Kuiper GA; Meijer OLM; Langereis EJ; Wijburg FA
    Orphanet J Rare Dis; 2018 Jan; 13(1):2. PubMed ID: 29310675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I.
    Giugliani R; Muschol N; Keenan HA; Dant M; Muenzer J
    Arch Dis Child; 2021 Jul; 106(7):674-679. PubMed ID: 33139350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.
    Pievani A; Azario I; Antolini L; Shimada T; Patel P; Remoli C; Rambaldi B; Valsecchi MG; Riminucci M; Biondi A; Tomatsu S; Serafini M
    Blood; 2015 Mar; 125(10):1662-71. PubMed ID: 25298037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
    Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
    Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First Three Years' Experience of Mucopolysaccharidosis Type-I Newborn Screening in California.
    Fillman T; Matteson J; Tang H; Mathur D; Zahedi R; Sen I; Bishop T; Neogi P; Feuchtbaum L; Olney RS; Sciortino S
    J Pediatr; 2023 Dec; 263():113644. PubMed ID: 37516270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.
    Shapiro EG; Nestrasil I; Rudser K; Delaney K; Kovac V; Ahmed A; Yund B; Orchard PJ; Eisengart J; Niklason GR; Raiman J; Mamak E; Cowan MJ; Bailey-Olson M; Harmatz P; Shankar SP; Cagle S; Ali N; Steiner RD; Wozniak J; Lim KO; Whitley CB
    Mol Genet Metab; 2015; 116(1-2):61-8. PubMed ID: 26095521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
    Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
    Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.
    Grosse SD; Lam WKK; Wiggins LD; Kemper AR
    Genet Med; 2017 Sep; 19(9):975-982. PubMed ID: 28125077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model.
    Visigalli I; Delai S; Politi LS; Di Domenico C; Cerri F; Mrak E; D'Isa R; Ungaro D; Stok M; Sanvito F; Mariani E; Staszewsky L; Godi C; Russo I; Cecere F; Del Carro U; Rubinacci A; Brambilla R; Quattrini A; Di Natale P; Ponder K; Naldini L; Biffi A
    Blood; 2010 Dec; 116(24):5130-9. PubMed ID: 20847202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.
    Eisengart JB; Rudser KD; Xue Y; Orchard P; Miller W; Lund T; Van der Ploeg A; Mercer J; Jones S; Mengel KE; Gökce S; Guffon N; Giugliani R; de Souza CFM; Shapiro EG; Whitley CB
    Genet Med; 2018 Nov; 20(11):1423-1429. PubMed ID: 29517765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome.
    Ahmed A; Whitley CB; Cooksley R; Rudser K; Cagle S; Ali N; Delaney K; Yund B; Shapiro E
    Mol Genet Metab; 2014 Feb; 111(2):123-7. PubMed ID: 24368159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arthropathy-like findings and a carpal tunnel syndrome as the presenting features of Scheie syndrome: Three cases from the same family.
    Gökay S; Kardaş F; Kendirci M; Sözeri B
    Turk J Pediatr; 2018; 60(3):344-347. PubMed ID: 30511553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.